EMA
approval
· 2022-02-25
New medicine for rare type of eye cancer
Summary
The EMA announces a new medicine addressing a rare eye cancer, marking an important regulatory milestone for an orphan indication.
Upgrade for the full analysis, importance score, and drug timeline.